Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NYMX NASDAQ:OXFD NASDAQ:RIOT NASDAQ:VIVO NASDAQ:VRML On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNYMXNymox Pharmaceutical$0.34$0.17▼$0.74$18.10M0.6494,622 shs932,700 shsOXFDOxford Immunotec Global$21.99$21.98$8.37▼$23.11$570.90M1.421.10 million shsN/ARIOTRiot Platforms$11.57+0.2%$9.47$6.19▼$15.87$4.13B4.5728.59 million shs18.29 million shsVIVOMeridian Bioscience$33.97$33.70$20.35▼$34.38$1.50B0.23973,737 shsN/AVRMLVermillion$0.17-0.5%$3.26$0.35▼$5.78$16.64M3.47440,144 shs159,319 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNYMXNymox Pharmaceutical0.00%0.00%0.00%0.00%0.00%OXFDOxford Immunotec Global0.00%0.00%0.00%0.00%0.00%RIOTRiot Platforms+0.17%+2.66%+17.46%+56.78%+23.09%VIVOMeridian Bioscience0.00%0.00%0.00%0.00%0.00%VRMLVermillion-0.52%+16.97%+64.96%+87.80%-84.60%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNYMXNymox PharmaceuticalN/AN/AN/AN/AN/AN/AN/AN/AOXFDOxford Immunotec GlobalN/AN/AN/AN/AN/AN/AN/AN/ARIOTRiot Platforms1.6587 of 5 stars3.52.00.00.01.50.80.0VIVOMeridian BioscienceN/AN/AN/AN/AN/AN/AN/AN/AVRMLVermillionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNYMXNymox Pharmaceutical 0.00N/AN/AN/AOXFDOxford Immunotec Global 0.00N/AN/AN/ARIOTRiot Platforms 3.09Buy$17.3549.96% UpsideVIVOMeridian Bioscience 0.00N/AN/AN/AVRMLVermillion 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NYMX, VIVO, VRML, OXFD, and RIOT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/17/2025RIOTRiot PlatformsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$12.00 ➝ $15.006/13/2025RIOTRiot PlatformsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$13.00 ➝ $14.005/2/2025RIOTRiot PlatformsNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$13.50 ➝ $12.004/28/2025RIOTRiot PlatformsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$23.00 ➝ $18.00(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNYMXNymox PharmaceuticalN/AN/AN/AN/A($0.01) per shareN/AOXFDOxford Immunotec Global$73.71M7.75$0.02 per share1,408.78$8.08 per share2.72RIOTRiot Platforms$376.66M10.97$0.94 per share12.35$9.14 per share1.27VIVOMeridian Bioscience$333.02M4.49$1.78 per share19.13$8.41 per share4.04VRMLVermillion$4.54M3.67N/AN/A$0.09 per share1.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNYMXNymox Pharmaceutical-$6.58M-$0.04N/AN/AN/AN/A-1,589.50%-117.25%N/AOXFDOxford Immunotec Global-$1.81M-$0.05N/AN/AN/A-30.51%-8.39%-7.63%N/ARIOTRiot Platforms$109.40M-$1.32N/AN/AN/A-86.93%-13.97%-11.99%7/30/2025 (Estimated)VIVOMeridian Bioscience$42.46M$0.9735.02∞N/A12.70%16.74%13.09%N/AVRMLVermillion-$15.24MN/AN/A∞N/A-307.31%-155.25%-103.47%N/ALatest NYMX, VIVO, VRML, OXFD, and RIOT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025RIOTRiot Platforms-$0.27N/AN/AN/A$146.66 millionN/A5/1/2025Q1 2025RIOTRiot Platforms-$0.25-$0.90-$0.65-$0.90$159.60 million$161.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNYMXNymox PharmaceuticalN/AN/AN/AN/AN/AOXFDOxford Immunotec GlobalN/AN/AN/AN/AN/ARIOTRiot PlatformsN/AN/AN/AN/AN/AVIVOMeridian BioscienceN/AN/AN/AN/AN/AVRMLVermillionN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNYMXNymox PharmaceuticalN/A0.190.19OXFDOxford Immunotec GlobalN/A15.9614.85RIOTRiot Platforms0.203.233.23VIVOMeridian Bioscience0.073.632.46VRMLVermillion0.202.512.49Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNYMXNymox Pharmaceutical1.14%OXFDOxford Immunotec Global91.90%RIOTRiot Platforms40.27%VIVOMeridian Bioscience89.72%VRMLVermillion18.09%Insider OwnershipCompanyInsider OwnershipNYMXNymox Pharmaceutical54.00%OXFDOxford Immunotec Global4.33%RIOTRiot Platforms6.93%VIVOMeridian Bioscience2.30%VRMLVermillion4.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNYMXNymox Pharmaceutical390.51 million41.64 millionOptionableOXFDOxford Immunotec Global27325.96 millionN/ANot OptionableRIOTRiot Platforms340357.26 million332.51 millionOptionableVIVOMeridian Bioscience70244.01 million43.00 millionOptionableVRMLVermillion4397.38 millionN/ANot OptionableNYMX, VIVO, VRML, OXFD, and RIOT HeadlinesRecent News About These CompaniesVermillion authorities investigate car vs building crashAugust 10, 2024 | keloland.comKVermillion, SD Hourly Weather ForecastApril 30, 2024 | wunderground.comWVermillion named Tree City USAApril 21, 2024 | siouxcityjournal.comSVermillion girls' basketball rallies to win Class A state titleMarch 13, 2024 | siouxcityjournal.comSPeoria police thwart school shooting; teen could be charged as an adultFebruary 18, 2024 | pjstar.comP2023 HW Vanguard: Dale VermillionOctober 15, 2023 | housingwire.comHGoodwill coming to VermillionSeptember 17, 2023 | siouxcityjournal.comSIn Telangana, Vermillion And Saffron Threads Were Used To Lure Women VotersSeptember 2, 2023 | outlookindia.comVermillion, SD 10-Day Weather ForecastJuly 17, 2023 | wunderground.comWA cold case without a crime: Inside the messy investigation into two missing SD teens in 1971June 21, 2023 | grandforksherald.comGCamellia VermillionJune 16, 2023 | health.usnews.comDr. Richard L. KnutsonJune 6, 2023 | health.usnews.comVermillion Elementary SchoolMay 24, 2023 | usnews.comDr. Kenneth J. VermillionMay 20, 2023 | health.usnews.comGolf: Vermillion Runner-Up At Huskies Invitational | Sports | plaintalk ... - Vermillion Plain TalkMay 13, 2023 | news.google.comNDriver killed after veering into path of dump truck on Highway 52 - Bring Me The NewsMay 13, 2023 | news.google.comNFatal crash in Vermillion Township closes portion of Highway 52 - CBS NewsMay 13, 2023 | news.google.comNVermillion, KS Weather ConditionsMay 13, 2023 | wunderground.comWVermillion Softball Falls To Tea Area 12-2 | Sports | plaintalk.net - Vermillion Plain TalkMay 13, 2023 | news.google.comNBaseball: Dakota Valley Blanks Vermillion 7-0 | Sports | plaintalk.net - Vermillion Plain TalkMay 13, 2023 | news.google.comNNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense3 Blockchain Stocks to Profit in a Decentralized WorldBy Chris Markoch | June 24, 2025View 3 Blockchain Stocks to Profit in a Decentralized WorldNYMX, VIVO, VRML, OXFD, and RIOT Company DescriptionsNymox Pharmaceutical NASDAQ:NYMXNymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.Oxford Immunotec Global NASDAQ:OXFDOxford Immunotec Global PLC, a diagnostics company, focuses on developing and commercializing proprietary tests for immunology and infectious diseases in the United States, Europe, Asia, and internationally. The company develops its products using its T-SPOT technology platform that measures marker-specific cellular (T cells) responses at a single cell level and inform the diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. It develops and markets T-SPOT.TB test used to test for tuberculosis; and reagents and methods to purify white blood cells for use in immunology assays. In addition, the company offers T-SPOT.CMV, an immune monitoring test for cytomegalovirus (CMV) for the quantification of effector T cells that respond to stimulation by antigens specific for CMV, as well as for the monitoring of CMV-seropositive responses in transplant recipients at various time-points post-transplantation applications. It serves independent laboratories, hospital systems, and public and private institutions. Oxford Immunotec Global PLC was founded in 2002 and is headquartered in Abingdon, the United Kingdom.Riot Platforms NASDAQ:RIOT$11.57 +0.02 (+0.17%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$11.64 +0.07 (+0.57%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.Meridian Bioscience NASDAQ:VIVOMeridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH.Vermillion NASDAQ:VRMLVermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women. It also offers in-vitro diagnostic (IVD) trial services to third-party customers; and laboratory services to meet the needs of IVD manufacturers to commercialize high-complexity assays. The company serves clinical reference laboratories, hospital laboratories, and physician offices. Vermillion, Inc. was founded in 1993 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Micron Insiders Sell But Investors Should Buy, Buy, Buy Believe the Hype? Can SoFi Maintain Its 3-Month Rally? Sizzling Insider Buys for Your High-Yield Watchlist Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
